Navigation Links
Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share
Date:12/19/2013

DUBLIN, Ireland and VILLA GUARDIA, Italy, Dec. 19, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Gentium S.p.A. (Nasdaq: GENT) today announced that they have entered into a definitive agreement pursuant to which a subsidiary of Jazz Pharmaceuticals will make a cash tender offer of $57.00 per share for all outstanding Gentium ordinary shares and American Depositary Shares, in a transaction that is valued at approximately $1 billion.

Gentium is a biopharmaceutical company focused on the development and manufacturing of therapies to treat and prevent a variety of rare diseases and conditions that currently have few or no treatment options, including orphan vascular diseases related to cancer treatments.  In October 2013, the European Commission granted marketing authorization for Defitelio™ (defibrotide), the company's lead product, for the treatment of severe hepatic veno-occlusive disease (VOD) in adults and children undergoing hematopoietic stem cell transplantation.

"The planned combination of Jazz Pharmaceuticals and Gentium is highly synergistic, as we both are dedicated to bringing highly differentiated therapies to patients who have high unmet medical needs," said Dr. Khalid Islam, chairman of the board of directors and chief executive officer of Gentium. "We believe that Jazz Pharmaceuticals' commercial and clinical expertise, and existing multi-national infrastructure, will help realize the value of Defitelio to patients, as the first treatment approved in the European Union (EU) for the treatment of severe hepatic VOD.  After thoroughly evaluating our strategic options, our board of directors has determined that this all-cash transaction is in the best interes
'/>"/>

SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Educational Grant Awarded to Winner of Ferring Pharmaceuticals Inaugural Heart to Heart Video Contest
2. Prolong Pharmaceuticals Adds Industry Veteran Ronald Jubin To Executive Management Team
3. Avista Capital Partners Announces a Majority Investment in Vertical Pharmaceuticals and Trigen Laboratories
4. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
5. Everett Laboratories Acquires Quinnova Pharmaceuticals to Diversify U.S. Pharmaceutical Presence
6. Smithers Quality Assessments Expands Certification Services to Include Pharmaceuticals Industry
7. Partnerships, Appointments, New Products, Public Offerings, and Agreements - Research Report on Questcor Pharmaceuticals, Hologic, IDEXX, Endologix, and Healthways
8. AcelRx Pharmaceuticals Presents ARX-04 Dose-Finding Phase 2 Study Data at Anesthesia Medical Conference
9. Auxilium Pharmaceuticals, Inc. Announces First Patient Dosed in Phase 2b Frozen Shoulder Syndrome Study of Collagenase Clostridium Histolyticum
10. Rafarma Pharmaceuticals Announces a $1.2 Million Private Placement
11. AcelRx Pharmaceuticals Adds New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... SAN DIEGO , July 30, 2015 ... announced it has signed a definitive agreement ... provider of non-invasive ventilation and sleep-disordered breathing ... strong clinical, innovation and market reputation in China, combined with ResMed,s global leadership ... of people in China ...
(Date:7/30/2015)... 2015  EP Global Communications, Inc. (Public OTC: EPGL) announced ... the Company about discussing EPGL,s electronic contact lens ... August 3, 2015.  Novartis CEO Joe Jimenez ... coming electronic contact lens market could be worth ... several years.  Novartis partnered with Google in 2014 ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) ... of 2015. Key results include: , Total ... of 2014 to $5,370 million, with 6 percent ... (etanercept), Prolia ® (denosumab), Sensipar ® ... ® (denosumab). Unfavorable changes in foreign exchange ...
Breaking Medicine Technology:ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23
... Calif., Feb. 25, 2011 Accuray Incorporated ... the field of radiosurgery, announced today that its Senior Vice ... was named "Best General Counsel, Small Public Company" by the ... San Francisco Business Times as part of their ,Best ...
... Landauer, Inc. (NYSE: LDR ) announced today that ... $0.55 per share for the second quarter of fiscal 2011.  The ... record on March 11, 2011. About Landauer ... analytical services to determine occupational and environmental radiation exposure and is ...
Cached Medicine Technology:Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 2Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 3Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award 4
(Date:7/30/2015)... ... July 30, 2015 , ... The ... BioPharma, Inc. are pleased to announce that data standards for clinical research in ... on the CDISC website . These three Therapeutic Area (TA) standards were ...
(Date:7/30/2015)... ... July 30, 2015 , ... In an effort to provide ... Aggarwal is making a change in his practice. , The decision will also allow ... 2015, Dr. Aggarwal will be transferring his in-patient admissions to the hospitalists at East ...
(Date:7/30/2015)... ... July 30, 2015 , ... Women's dating ... Lines ." It's for women interested in improving their love lives using specific ... which officially launched to the public early this morning, has drawn praise from ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... In a ... clients at Serenity Palms Drug Addiction Treatment Center have created an addiction graveyard. Sharing ... one of its most beloved residents, Rocky Hudson . Hudson (1945-2015) fell in ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... is the recipient of three awards in the Service Industry Advertising Awards 12th ... for Choptank Transport, KRM Development Corporation and University of Maryland Shore Regional Health. ...
Breaking Medicine News(10 mins):Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 2Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 3Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 4Health News:CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3
... the all-natural weight management program, opened in Ottawa with the ... began their weight-loss journey on the Smart for Life(TM) program ... for 6 family members. As friends and relatives joined the ... exciting business opportunity. , "Smart for Life(TM) is ...
... and services company focused on global eClinical solutions for the clinical ... studies from European Sponsor clients. These new studies will seek to ... as the Indian subcontinent. , "We ... to be a direct result of our continued hard work in ...
... ... and CEO of Abraxis Health, will receive the Adaptive Business Leaders Organization,s 2009 ... Awards Event on October 28, in Newport Beach. , ... Santa Ana, CA (PRWEB) October ...
... ... launch of their "Tats for Tatas" fundraising campaign that will take place ... the company,s concerted efforts to raise awareness and funds for Breast Cancer ... the company will be donating 10% of all proceeds from sales throughout ...
... Pa., Oct. 15 Herley Industries, Inc. (Nasdaq: HRLY ... Fiscal Year ended August 2, 2009. , Fourth Quarter ... quarter of fiscal 2009 were $43.0 million compared to $37.9 ... fourth quarter of fiscal 2009, the Company recorded several significant ...
... Minnesota Nurses Point to Benefits for Patients, Nurse Staffing and ... A new Senate bill introduced today by Sen. Al ... of RNs in hospitals and other health care facilities, but ... transported and moved in the safest way possible, all while ...
Cached Medicine News:Health News:Smart for Life(TM) Center Opens in Ottawa 2Health News:DATATRAK Announces the Award of New Studies from European Pharmaceutical Clients 2Health News:DATATRAK Announces the Award of New Studies from European Pharmaceutical Clients 3Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 2Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 3Health News:Patrick Soon-Shiong, World Renowned Healthcare Visionary & Philanthropist, to Receive ABL's Leadership Award & Make Keynote Presentation, October 28, in Newport Beach 4Health News:Atomic Tattoos Announces "Tats for Tatas" October Fundraising Event to Benefit Local Breast Cancer Research 2Health News:Herley Reports Fourth Quarter and Year-End Results 2Health News:Herley Reports Fourth Quarter and Year-End Results 3Health News:Herley Reports Fourth Quarter and Year-End Results 4Health News:Herley Reports Fourth Quarter and Year-End Results 5Health News:Herley Reports Fourth Quarter and Year-End Results 6Health News:Herley Reports Fourth Quarter and Year-End Results 7Health News:Herley Reports Fourth Quarter and Year-End Results 8Health News:Herley Reports Fourth Quarter and Year-End Results 9Health News:Herley Reports Fourth Quarter and Year-End Results 10Health News:Herley Reports Fourth Quarter and Year-End Results 11Health News:Herley Reports Fourth Quarter and Year-End Results 12Health News:Nation's RNs Hail Sen. Franken's Support for Safe Patient Handling Measure 2
... opticians in a store environment. Optizone ... retail store industry by opticians. Optizone ... for Optizone 2000. It is written ... User friendly screen interfaces make learning ...
This product offers patient, product and practice cash management to ease the strain of practice administration....
... MaximEyes by First Insight is the ... records solution for eye care professionals. ... with Eyefinitys online servicesrequest VSP authorizations, ... MaximEyes offers EMR, scheduling, billing, demographics, ...
... software for eyecare professionals- Winx ... multi-office practice management system, using ... Winx Pro is a complete ... in effectively managing the administrative, ...
Medicine Products: